Evidence map›Paper›PMID 26090335›Full record

ArticleCardiovascular diagnosis and therapy2015

The World Hypertension League: where now and where to in salt reduction.

Norm R C Campbell, Daniel T Lackland, Liu Lisheng, Xin-Hua Zhang, Peter M Nilsson, Mark L Niebylski, World Hypertension League Executive

Abstract read
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Characteristics of Cerebral Stroke in the Tibet Autonomous Region of China.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Norm R C Campbell1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
Daniel T Lackland1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
Liu Lisheng1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
Xin-Hua Zhang1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
Peter M Nilsson1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
Mark L Niebylski1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
World Hypertension League Executive

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High dietary salt is a leading risk for death and disability largely by causing increased blood pressure. Other associated health risks include gastric and renal cell cancers, osteoporosis, renal stones, and increased disease activity in multiple sclerosis, headache, increased body fat and Meniere's disease. The World Hypertension League (WHL) has prioritized advocacy for salt reduction. WHL resources and actions include a non-governmental organization policy statement, dietary salt fact sheet, development of standardized nomenclature, call for quality research, collaboration in a weekly salt science update, development of a process to set recommended dietary salt research standards and regular literature reviews, development of adoptable power point slide sets to support WHL positions and resources, and critic of weak research studies on dietary salt. The WHL plans to continue to work with multiple governmental and non-governmental organizations to promote dietary salt reduction towards the World Health Organization (WHO) recommendations.

Indexed as

blood pressurehypertensionpublic healthSaltsodium

Identifiers

PMID26090335
PMCPMC4451312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.